Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Hearing

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Gut|August 14, 1999
Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytesS D Hearing, M Norman, C S Probert, et al.
Postgraduate Medical Journal|September 8, 2009
Social networking sites: a novel portal for communicationA D Farmer, C E M Bruckner Holt, M J Cook, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|April 28, 2007
Assessment by a multidisciplinary clinical nutrition team before percutaneous endoscopic gastrostomy placement reduces early postprocedure mortalityI Tanswell, D Barrett, C Emm, et al.
The Journal of the Royal College of Physicians of Edinburgh|December 3, 2010
The routine use of a flumazenil infusion following percutaneous endoscopic gastrostomy placement to reduce early post-procedure mortalityN C Bosanko, D Barrett, C Emm, et al.
Gut|June 13, 2003
Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trialC S J Probert, S D Hearing, S Schreiber, et al.
Alimentary Pharmacology & Therapeutics|May 21, 2003
Refeeding syndrome: effective and safe treatment with Phosphates PolyfusorA Terlevich, S D Hearing, W W Woltersdorf, et al.
Alimentary Pharmacology & Therapeutics|May 4, 2006
Basiliximab for the treatment of steroid-resistant ulcerative colitis: further experience in moderate and severe diseaseT J Creed, C S J Probert, M N Norman, et al.
Alimentary Pharmacology & Therapeutics|November 28, 2002
Is your patient taking the medicine? A simple assay to measure compliance with 5-aminosalicylic acid-containing compoundsI S Shaw, B A Jobson, D Silverman, et al.
Alimentary Pharmacology & Therapeutics|July 10, 2003
Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitisT J Creed, M R Norman, C S J Probert, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Gut|August 14, 1999
Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytesS D Hearing, M Norman, C S Probert, et al.
Postgraduate Medical Journal|September 8, 2009
Social networking sites: a novel portal for communicationA D Farmer, C E M Bruckner Holt, M J Cook, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|April 28, 2007
Assessment by a multidisciplinary clinical nutrition team before percutaneous endoscopic gastrostomy placement reduces early postprocedure mortalityI Tanswell, D Barrett, C Emm, et al.
The Journal of the Royal College of Physicians of Edinburgh|December 3, 2010
The routine use of a flumazenil infusion following percutaneous endoscopic gastrostomy placement to reduce early post-procedure mortalityN C Bosanko, D Barrett, C Emm, et al.
Gut|June 13, 2003
Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trialC S J Probert, S D Hearing, S Schreiber, et al.
Alimentary Pharmacology & Therapeutics|May 21, 2003
Refeeding syndrome: effective and safe treatment with Phosphates PolyfusorA Terlevich, S D Hearing, W W Woltersdorf, et al.
Alimentary Pharmacology & Therapeutics|May 4, 2006
Basiliximab for the treatment of steroid-resistant ulcerative colitis: further experience in moderate and severe diseaseT J Creed, C S J Probert, M N Norman, et al.
Alimentary Pharmacology & Therapeutics|November 28, 2002
Is your patient taking the medicine? A simple assay to measure compliance with 5-aminosalicylic acid-containing compoundsI S Shaw, B A Jobson, D Silverman, et al.
Alimentary Pharmacology & Therapeutics|July 10, 2003
Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitisT J Creed, M R Norman, C S J Probert, et al.
Pageof 2